'Influenza vaccines' diaporamas de présentation

Pandemic Influenza

Pandemic Influenza. Dr. Stefano Lazzari Director, WHO - Lyon Department of Epidemic and Pandemic Alert and Response. Hosted by Paul Webber paul@webbertraining.com www.webbertraining.com. Outline. The virus The disease Avian influenza Pandemic influenza. THE INFLUENZA VIRUS.

908 views • 61 slides

2013 MPA SPRING CONFERENCE

GREGORY CAMERON, R.Ph ASSISTANT PROFESSOR OF PHARMACY PRACTICE FIELD COORDINATOR COMMUNITY/AMBULATORY SITES HUSSON UNIVERSITY SCHOOL OF PHARMACY. 2013 MPA SPRING CONFERENCE. Pillows are available upon request!!!!. Please Silence All Electronic Equipment. 2013 MPA SPRING CONFERENCE.

727 views • 55 slides

Seasonal and Pandemic Influenza Vaccines : Vaccine Development and Production

Seasonal and Pandemic Influenza Vaccines : Vaccine Development and Production. Learning Objectives. Develop a basic understanding of how influenza vaccines are developed Be familiar with the major types of vaccines and methods of vaccine production

746 views • 55 slides

M. A. El-Farrash

M. A. El-Farrash. ?? ??? ????? ????? ???? A( H1N1) ?????? ?? ????? ??? ??? ???? ??????? ????? ???. ???????: ???? ????? ???? ????? ???? ????? ????? ????? ??????? ?????? ?? ????? ??? ????? ?????? ?? ???? ????? ????? .

630 views • 52 slides

Influenza and Influenza Vaccines

Influenza and Influenza Vaccines. K. Vahdat 25/11/1391. Influenza. Highly infectious viral illness Epidemics reported since 16 th century. Influenza Virus Strains. Type A moderate to severe illness all age groups humans and other animals Type B changes less rapidly than type A

655 views • 42 slides

Chapter 92

Chapter 92. Antiviral Agents I: Drugs for Non-HIV Viral Infections. Antiviral Therapy. Our ability to treat viral infections remains limited Viruses use biochemical machinery of host cells to reproduce Difficult to suppress viral replication without doing significant harm to the host

549 views • 34 slides

Report to the VRBPAC on the Site Visit for the Laboratory of DNA Viruses

Report to the VRBPAC on the Site Visit for the Laboratory of DNA Viruses. Keith Peden, PhD Chief, Laboratory of DNA Viruses May 8, 2013. Organization of the Laboratory of DNA Viruses Laboratory of DNA Viruses Chief: Keith Peden, PhD. Unit on Viral Latency Phil Krause, PI Shuang Tang

451 views • 31 slides

351 views • 28 slides

Seasonal Influenza: Vaccines & Prevention

Seasonal Influenza: Vaccines & Prevention. Kristin Nichol, MD, MPH, MBA Professor of Medicine University of Minnesota Chief of Medicine and Director Primary Care Service Line Minneapolis VA Medical Center Minneapolis, MN. Overview.

479 views • 26 slides

Influenza Presentation

Influenza Presentation. Agenda. What Is Influenza? Vaccine Testing and Safety Impact of Influenza Recommended Recipients Influenza Vaccines and Components Side Effects and Contra-indications Dosage and Administration Myths and Misconceptions Questions and Discussion. What is Influenza?.

530 views • 22 slides

Welcome To eMAR Update

312 views • 21 slides

Johns Hopkins Vaccine Initiative

530 views • 21 slides

Influenza Presentation

Influenza Presentation. Presented by:. The Brant County Health Unit. AGENDA. What Is Influenza? Vaccine Testing and Safety Impact of Influenza Recommended Recipients Influenza Vaccines and Components Side Effects and Contra-indications Dosage and Administration Myths and Misconceptions

443 views • 20 slides

Overview of the Division of Viral Products

Overview of the Division of Viral Products. Jerry P. Weir, Ph.D. Director Division of Viral Products/OVRR/CBER/FDA. Mission. Regulate viral vaccines and related biological products, ensuring their safety and efficacy for human use

351 views • 16 slides

Influenza Vaccine Considerations 2014-2015 Season

Influenza Vaccine Considerations 2014-2015 Season. Alicia Vanden Bosch, PharmD Creighton University SPAHP September, 2014. Who Should Get Influenza Vaccine?.

336 views • 16 slides

Healthcare Personnel

Healthcare Personnel . All paid and unpaid persons working in healthcare settings who have the potential for exposure to patients and/or to infectious materials. Measles. Between 2001 and 2010 approximately 60 reported measles cases annually in the U.S.

363 views • 15 slides

SAFETY OF INFLUENZA VACCINATION

SAFETY OF INFLUENZA VACCINATION. Symptom. Vaccine (%). Placebo (%). Feverish. 5.7. 4.2. Malaise. 7.2. 6.3. Myalgia. 4.8. 4.2. Headache. 6.9. 7.6. Nausea. 4.5. 2.4. Sore arm. 20.1. 4.9. Influenza vaccine post - injection symptoms in elderly subjects.

207 views • 8 slides

194 views • 7 slides

Seasonal Influenza Vaccine Market in Asia - Pacific Region

Seasonal Influenza Vaccine Market in the Asia-Pacific Region is Forecast to Show High Growth

455 views • 6 slides

How many flu episodes/year How many are influenza?

How many flu episodes/year How many are influenza?. Many viruses. Influenza A or B. N=93. N=100 No flu episodes. N=7 Flu episodes. Based on 274 influenza vaccines and 28 epi studies 1966-2007 (> 3 M observations).

163 views • 4 slides